|
| Batefenterol Basic information |
Product Name: | Batefenterol | Synonyms: | Batefenterol;(R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate;GSK-961081,Batefenterol;GSK961081;GSK-961081;GSK 961081;TD-5959;TD 5959;TD5959;BATEFENTEROL;GSK-961081(Batefenterol/TD-5959);Batefenterol, 98%, a novel muscarinic receptor antagonist and β2-adrenoceptor agonist;Batefenterol(GSK961081);Carbamic acid, N-[1,1'-biphenyl]-2-yl-, 1-[3-[[2-chloro-4-[[[(2R)-2-(1,2-dihydro-8-hydroxy-2-oxo-5-quinolinyl)-2-hydroxyethyl]amino]methyl]-5-methoxyphenyl]amino]-3-oxopropyl]-4-piperidinyl ester | CAS: | 743461-65-6 | MF: | C40H42ClN5O7 | MW: | 740.24 | EINECS: | | Product Categories: | APIs | Mol File: | 743461-65-6.mol | |
| Batefenterol Chemical Properties |
Boiling point | 948.3±65.0 °C(Predicted) | density | 1.41±0.1 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO:67.0(Max Conc. mg/mL);90.51(Max Conc. mM) | form | A crystalline solid | pka | 8.89±0.20(Predicted) | color | Light yellow to yellow |
| Batefenterol Usage And Synthesis |
| Batefenterol Preparation Products And Raw materials |
|